| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| gl-0817 | melanoma-associated antigen 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Cancer of Head and Neck[MeSHID:D006258] Squamous cell carcinoma[MeSHID:D002294] |
31.83 | phase 2 | unknown |
| click here to return to the previous page | ||||||||